After opening an office in Tampa, Florida, in 2014 and filling hundreds of positions, Bristol-Myers Squibb plans to lay off dozens of employees there early next year.
Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy.
After more than 50 years in Arnhem, the Netherlands, Novartis has decided to move its Dutch operations to Amsterdam, the new home of the European Medicines Agency (EMA).